Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptor.

Chu CS, Wang YC, Lu LS, Walton B, Yilmaz HR, Huang RY, Sawamura T, Dixon RA, Lai WT, Chen CH, Lu J.

PLoS One. 2013 Aug 8;8(8):e70533. doi: 10.1371/journal.pone.0070533. eCollection 2013.

2.

Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.

Lu J, Yang JH, Burns AR, Chen HH, Tang D, Walterscheid JP, Suzuki S, Yang CY, Sawamura T, Chen CH.

Circ Res. 2009 Mar 13;104(5):619-27. doi: 10.1161/CIRCRESAHA.108.190116. Epub 2009 Jan 15.

3.

Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.

Stancel N, Chen CC, Ke LY, Chu CS, Lu J, Sawamura T, Chen CH.

Clin Chem. 2016 Feb;62(2):320-7. doi: 10.1373/clinchem.2015.243923. Epub 2015 Nov 25. Review.

4.

Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1.

Tang D, Lu J, Walterscheid JP, Chen HH, Engler DA, Sawamura T, Chang PY, Safi HJ, Yang CY, Chen CH.

J Lipid Res. 2008 Jan;49(1):33-47. Epub 2007 Oct 1.

5.

3'UTR/T polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects.

Puccetti L, Pasqui AL, Pastorelli M, Ciani F, Palazzuoli A, Gioffrè W, Auteri A, Bruni F.

Atherosclerosis. 2005 Dec;183(2):322-8. Epub 2005 Apr 22.

PMID:
16285995
6.
7.
8.

Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia.

Puccetti L, Bruni F, Pasqui AL, Pastorelli M, Ciani F, Palazzuoli A, Acampa M, Auteri A.

Eur J Clin Invest. 2008 Jan;38(1):11-6. doi: 10.1111/j.1365-2362.2007.01891.x.

PMID:
18173546
9.

Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation.

Shen MY, Chen FY, Hsu JF, Fu RH, Chang CM, Chang CT, Liu CH, Wu JR, Lee AS, Chan HC, Sheu JR, Lin SZ, Shyu WC, Sawamura T, Chang KC, Hsu CY, Chen CH.

Blood. 2016 Mar 10;127(10):1336-45. doi: 10.1182/blood-2015-05-646117. Epub 2015 Dec 17.

10.

Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.

Puccetti L, Sawamura T, Pasqui AL, Pastorelli M, Auteri A, Bruni F.

Eur J Clin Invest. 2005 Jan;35(1):47-51.

PMID:
15638819
11.

Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction.

Chang PY, Chen YJ, Chang FH, Lu J, Huang WH, Yang TC, Lee YT, Chang SF, Lu SC, Chen CH.

Cardiovasc Res. 2013 Jul 1;99(1):137-45. doi: 10.1093/cvr/cvt062. Epub 2013 Mar 20.

PMID:
23519265
12.

Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.

Hossain E, Ota A, Karnan S, Damdindorj L, Takahashi M, Konishi Y, Konishi H, Hosokawa Y.

Toxicol Appl Pharmacol. 2013 Dec 15;273(3):651-8. doi: 10.1016/j.taap.2013.10.012. Epub 2013 Oct 19.

PMID:
24145059
13.

Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription.

Chen CH, Jiang T, Yang JH, Jiang W, Lu J, Marathe GK, Pownall HJ, Ballantyne CM, McIntyre TM, Henry PD, Yang CY.

Circulation. 2003 Apr 29;107(16):2102-8. Epub 2003 Apr 14.

14.

Electronegative low-density lipoprotein induces cardiomyocyte apoptosis indirectly through endothelial cell-released chemokines.

Lee AS, Wang GJ, Chan HC, Chen FY, Chang CM, Yang CY, Lee YT, Chang KC, Chen CH.

Apoptosis. 2012 Sep;17(9):1009-18. doi: 10.1007/s10495-012-0726-1.

PMID:
22562555
15.

Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment.

Puccetti L, Pasqui AL, Bruni F, Pastorelli M, Ciani F, Palazzuoli A, Pontani A, Ghezzi A, Auteri A.

Int J Cardiol. 2007 Jun 25;119(1):41-7. Epub 2006 Oct 13.

PMID:
17050011
16.
17.

Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.

Zhao W, Ma G, Chen X.

Vascul Pharmacol. 2014 Dec;63(3):162-72. doi: 10.1016/j.vph.2014.06.008. Epub 2014 Aug 16.

PMID:
25135647
18.

Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects.

Fujita Y, Kakino A, Nishimichi N, Yamaguchi S, Sato Y, Machida S, Cominacini L, Delneste Y, Matsuda H, Sawamura T.

Clin Chem. 2009 Feb;55(2):285-94. doi: 10.1373/clinchem.2008.119750. Epub 2008 Dec 12.

19.

Pitavastatin reduces lectin-like oxidized low-density lipoprotein receptor-1 ligands in hypercholesterolemic humans.

Matsumoto T, Fujita M, Sawamura T, Kakino A, Sato Y, Fujita Y, Matsuda H, Nakanishi M, Uchida K, Nakae I, Kanda H, Yoshida A, Miwa K, Hayashi H, Mitsunami K, Horie M.

Lipids. 2010 Apr;45(4):329-35. doi: 10.1007/s11745-010-3402-7. Epub 2010 Mar 13.

PMID:
20229124
20.

Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.

Matsuda N, Ohkuma H, Naraoka M, Munakata A, Shimamura N, Asano K.

J Neurosurg. 2014 Sep;121(3):621-30. doi: 10.3171/2014.5.JNS132140. Epub 2014 Jun 20.

PMID:
24949677

Supplemental Content

Support Center